Xeriant director Edward DeFeudis resigns; Mark Sternberg elected

XERIANT, INC.

Edward DeFeudis resigned as director effective March 31, 2025, with no disagreement with company.
Mark Sternberg elected director effective March 31, 2025; had been on Board of Advisors since Jan 14, 2025.
Sternberg granted 1,000,000 shares vesting quarterly; $2,500 per meeting in cash/shares.
Sternberg receives $25,000 in shares at end of each year of service plus additional BD/IP/patent comp.
Sternberg brings 30+ years experience in nano-coatings design, manufacturing, and patents.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Edward DeFeudis

Director

XERI · XERIANT, INC.

Effective: 2025-03-31
Filed: April 2, 2025, 7:59 PM ET

Effective March 31, 2025, Edward DeFeudis resigned as a director of Xeriant, Inc. (the “Company”).

Appointed

Mark Sternberg

Director

XERI · XERIANT, INC.

Effective: 2025-03-31
Filed: April 2, 2025, 7:59 PM ET

Effective March 31, 2025, Mark Sternberg was elected as a director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Edward DeFeudis resigned as Director at XERIANT, INC..

Action: resigned
Role: Director

Exact text from the filing

Effective March 31, 2025, Edward DeFeudis resigned as a director of Xeriant, Inc. (the “Company”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Sternberg was elected as Director at XERIANT, INC..

Action: elected
Role: Director

Exact text from the filing

Effective March 31, 2025, Mark Sternberg was elected as a director of the Company.

View on SEC.gov

XERIANT, INC. filing history →

Source: SEC EDGAR

accession 0001477932-25-002373

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.